Intrinsiqs

Is Ligand Pharmaceuticals Incorporated overvalued?

Ligand Pharmaceuticals Incorporated (LGND) looks overvalued — trading about 34% above its fair value.

Overvalued
Current price $301.52 Fair value $197.56
Price
$301.52
Fair value
$197.56
Current P/E
36.2
Normal P/E
23.7
Market cap
$6.04B
Dividend yield
0.0%
Return on equity
20.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LGND's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated